+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Blood Agar Plate Medium Market by Type (Dehydrated Powder, Pre Poured Plates, Ready to Use), Application (Clinical Diagnostics, Food Safety Testing, Pharmaceutical Manufacturing), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6134302
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Understanding the pivotal role of blood agar plate medium in microbiological characterization underscores its enduring significance in both research and clinical settings. As an enriched growth substrate, it enables the cultivation of fastidious microorganisms, thereby facilitating precise identification of pathogens and the assessment of hemolytic patterns that inform antibiotic therapy decisions. Its adoption spans diverse applications, from fundamental microbial physiology studies to high-stakes diagnostic workflows, reflecting its versatility and scientific rigor.

In recent years, the medium’s formulation and deployment have evolved in response to advances in blood source processing and quality control standards. Innovations in powder dehydration techniques and pre poured plate production have enhanced media consistency, reduced contamination risks, and streamlined laboratory workflows. Simultaneously, the emergence of ready to use formats has addressed the growing demand for convenience and rapid turnaround, enabling laboratories to deliver timely results without the burden of in-house media preparation.

Consequently, stakeholders across academic institutes, diagnostic laboratories, and pharmaceutical manufacturers regard blood agar plate medium as a foundational tool. This introduction sets the stage for a comprehensive exploration of transformative shifts, regulatory influences, and competitive dynamics shaping the market, ultimately providing a clear framework for strategic decision-making in this indispensable segment of microbiological media.

Examining the Most Impactful Technological Regulatory and Methodological Shifts Reshaping the Blood Agar Plate Medium Ecosystem in 2025

The landscape of blood agar plate medium is undergoing profound transformation driven by a convergence of technological, regulatory, and methodological shifts. Automation in media preparation and inoculation systems has begun to redefine laboratory throughput, while digital imaging and artificial intelligence-powered colony recognition tools are accelerating phenotypic analyses. These technological advancements are enabling microbiologists to allocate more time to interpretation and research design rather than routine manual tasks.

At the same time, regulatory agencies worldwide are tightening quality standards for blood sources, imposing stricter traceability requirements for animal and human blood powders. These measures aim to minimize contamination risks and ensure biosafety, prompting manufacturers to invest in advanced screening protocols and certification processes. As a result, the cost structure for producing dehydrated powders and pre poured plates has evolved, influencing pricing strategies and supply chain resilience.

Moreover, the methodological shift toward multiplexed and high-throughput susceptibility testing is reshaping application paradigms within clinical diagnostics and pharmaceutical screenings. Researchers are increasingly integrating hemolysis assays with genomic and proteomic workflows, thereby extracting richer data from a single culture run. Together, these transformative shifts are catalyzing a new era of efficiency, precision, and regulatory compliance in blood agar plate medium utilization, with far-reaching implications for end users and supply network participants alike.

Analyzing the Multi Dimensional Effects of United States Tariff Policies on Supply Chain Costs Innovation Dynamics and Market Accessibility for Blood Agar Plate Medium

United States tariff policies have imposed multifaceted influences on the blood agar plate medium market, affecting raw material accessibility, production economics, and cross-border collaboration. Tariffs on imported animal blood powders, including equine, human, and ovine derivatives, have elevated input costs for dehydrated formulations. These cost pressures cascade through the value chain, compelling manufacturers to reevaluate sourcing strategies and localize certain production stages to mitigate financial impact.

Simultaneously, tariff-induced supply constraints have expedited the qualification of alternative blood suppliers, resulting in diversified procurement networks that emphasize geographic redundancy. This shift has reinforced the importance of robust supplier audits and contingency planning, ensuring that critical media components remain consistently available for pre poured plate and ready to use offerings. As a consequence, distribution channel partners have adapted their inventory models, balancing direct sales commitments with distributor stock levels to absorb tariff volatility.

Furthermore, the cumulative effect of these tariffs has driven innovation in blood substitute formulations and lyophilized powder technologies, as producers seek to circumvent import barriers while maintaining performance standards. Research laboratories and pharmaceutical companies have responded by investing in in-house validation protocols to verify equivalence between legacy and newly sourced blood powders. In this way, the tariff environment has not only imposed economic challenges but has also accelerated adaptive strategies in formulation development and risk management across the ecosystem.

Unlocking Critical Market Perspectives Through In Depth Examination of Type Application End User and Distribution Channel Segmentation Dimensions

A nuanced appreciation of market segmentation reveals distinct dynamics when examining the influence of medium type, application area, end user category, and distribution pathway. Within the type dimension, dehydrated powder dominates through variants like horse blood powder, human blood powder, and sheep blood powder, each chosen for its specific hemolytic profile and compatibility with diverse microbial species. Parallel to this, pre poured plates and ready to use formats offer laboratories immediate deployment, appealing to clinical diagnostics teams seeking rapid turnaround and standardized performance.

Turning to applications, clinical diagnostics continues to lead through core activities such as antibiotic susceptibility testing and bacterial infection diagnosis, while food safety testing laboratories leverage blood agar’s selectivity to detect contamination by pathogenic bacteria. In pharmaceutical manufacturing, the medium underpins sterility assurance and batch release protocols, whereas research laboratories apply it to novel microbial interactions and pathogenic mechanism studies, deriving critical insights into microbial physiology.

End user segmentation further illustrates heterogeneity: academic and research institutes employ blood agar in fundamental science investigations, diagnostic laboratories integrate it into patient care workflows, hospitals and clinics depend on it for urgent infection identification, and pharmaceutical companies utilize it for stringent quality control. Distribution channels also play a pivotal role, with direct sales enabling bespoke order management, distributors ensuring regional availability, and online sales platforms expanding accessibility to remote or specialized facilities. Together, these segmentation insights inform targeted strategies for product development, marketing, and supply chain optimization.

Unveiling Regional Performance Patterns and Strategic Imperatives Across Americas Europe Middle East and Africa and Asia Pacific Markets for Blood Agar Plate Medium

Regional analysis highlights distinctive patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific territories, each shaped by varying economic conditions, regulatory frameworks, and infrastructure maturity. In the Americas, a strong network of clinical research institutions and high demand for rapid diagnostic tools drive robust consumption of pre poured and ready to use formats, while progressive regulatory guidelines ensure consistent quality across blood sourcing.

Across Europe, Middle East & Africa, stringent biosafety regulations and harmonized standards catalyze investment in certified suppliers of horse, human, and sheep blood powders. Market participants in this region often collaborate through pan-European consortia to streamline validation processes and reduce duplication of testing. In contrast, the Asia-Pacific arena presents rapid growth potential as emerging economies expand laboratory capabilities, particularly in food safety testing and pharmaceutical manufacturing sectors. Here, distributors and online sales channels play an increasingly vital role in bridging infrastructure gaps and enabling timely delivery to remote research facilities.

Consequently, regional strategies must adapt to localized demand drivers and compliance landscapes. Manufacturers and service providers achieve optimal reach by aligning product portfolios with regional preferences, reinforcing quality assurance initiatives, and fostering strategic partnerships that enhance supply continuity and technical support across each distinct geography.

Profiling Leading Industry Participants to Understand Competitive Strategies Product Innovations Collaborations and Growth Trajectories Shaping the Market Landscape

Key players in the blood agar plate medium market have leveraged diverse strategies to secure competitive advantage and stimulate growth. Global life sciences giants have focused on expanding their premium pre poured plate portfolios through acquisitions and strategic alliances, thereby reinforcing their geographic footprint and enhancing production capabilities. Concurrently, specialized medium manufacturers have concentrated on optimizing dehydrated powder formulations, introducing high-purity horse and sheep blood powders that meet stringent regulatory specifications and reduce batch-to-batch variability.

Innovation-driven companies are increasingly investing in automation partnerships and digital quality control systems to elevate manufacturing efficiency and traceability. Collaborations between media producers and instrument vendors have yielded integrated solutions that streamline workflow from inoculation to colony analysis. At the same time, agile regional distributors and online platforms continue to differentiate themselves through rapid lead times, localized technical support, and flexible order quantities that cater to small and mid-sized laboratories.

Moreover, several organizations are pioneering research into synthetic blood substitutes and recombinant hemoglobin technologies to alleviate reliance on traditional blood sources. These initiatives, while nascent, promise to diversify the product pipeline and address ethical and supply chain constraints. Through these varied approaches, leading companies are shaping the competitive landscape, driving product innovation, and setting new benchmarks for quality and service in the blood agar plate medium sector.

Delivering Strategic Data Driven Recommendations to Empower Industry Leaders in Optimizing Operations Driving Innovation and Capitalizing on Emerging Opportunities

Industry leaders should prioritize strategic investments in automation technologies and digital quality assurance tools to enhance production throughput and minimize variability. By integrating robotic media preparation systems and real-time monitoring platforms, organizations can achieve significant efficiency gains while maintaining stringent compliance with biosafety and purity standards. Furthermore, forging partnerships with instrumentation providers will enable end-to-end workflow optimization, from sample inoculation through image-based colony characterization.

In addition, companies must diversify supply bases for animal and human blood powders to mitigate the risks posed by tariff fluctuations and regulatory changes. Establishing multi-regional sourcing agreements and qualifying alternative suppliers can safeguard raw material continuity and reduce dependency on single geographies. Concurrently, investing in the development of recombinant hemoglobin and synthetic blood matrices will position organizations at the forefront of sustainable innovation, addressing both ethical concerns and supply limitations.

Finally, tailoring product offerings to the specific needs of academic centers, diagnostic laboratories, hospitals, and pharmaceutical firms will unlock new revenue streams. Customized packaging, flexible order volumes, and targeted technical support programs will resonate with diverse end users. By adopting these actionable recommendations, industry leaders can drive operational resilience, accelerate innovation, and capitalize on emerging opportunities within the evolving blood agar plate medium market.

Detailing the Comprehensive Research Design Data Collection Techniques and Analytical Frameworks Employed to Ensure Rigorous Reliable Market Insights

This research employed a rigorous, multi‐tiered methodology to ensure the validity and reliability of its insights. Initially, a comprehensive secondary research phase synthesized data from peer‐reviewed journals, regulatory filings, and white papers related to blood agar plate medium composition, quality standards, and application trends. Concurrently, industry reports and public financial disclosures provided contextual understanding of competitive dynamics and supply chain structures.

Subsequently, primary research was conducted through structured interviews with senior microbiologists, quality control managers, and procurement specialists from academic institutes, clinical laboratories, and pharmaceutical companies. These conversations elucidated real-world challenges, emerging use cases, and procurement preferences. Furthermore, an extensive survey across regional distribution partners captured quantitative data on lead times, pricing pressures, and customer service expectations.

The collected data underwent rigorous triangulation, leveraging statistical validation techniques and cross‐referencing insights across multiple sources to minimize bias. Analytical frameworks encompassing SWOT analysis, Porter’s Five Forces, and segmentation impact assessments were applied to distill strategic implications. Finally, all findings were peer‐reviewed by subject matter experts to ensure technical accuracy and relevance, culminating in a robust, actionable body of market intelligence.

Summarizing Core Findings Strategic Implications and Future Outlook to Provide Stakeholders with a Cohesive Understanding of the Blood Agar Plate Medium Market

In conclusion, the blood agar plate medium sector stands at a strategic inflection point defined by technological innovations, evolving regulatory mandates, and shifting supply chain paradigms. Advances in automation, AI-driven analysis, and ready to use formats are streamlining laboratory operations, while heightened quality standards for blood powders are reinforcing biosafety and traceability. The cumulative impact of United States tariffs has catalyzed diversification in sourcing strategies and propelled investments in synthetic alternatives, underscoring the market’s adaptive resilience.

Segmentation analysis reveals nuanced opportunities across dehydrated powder, pre poured plates, and ready to use media, as well as in applications spanning clinical diagnostics, food safety, pharmaceutical manufacturing, and research. Regional insights highlight distinct growth drivers in the Americas, Europe, Middle East & Africa, and Asia-Pacific, necessitating tailored go-to-market approaches. Leading companies are forging alliances, refining formulations, and exploring recombinant technologies to maintain competitive advantage.

Stakeholders equipped with this comprehensive intelligence can navigate emerging challenges, optimize operational efficiencies, and innovate product offerings that meet evolving end user requirements. By aligning strategic priorities with data-driven insights, organizations will be well positioned to capture growth and shape the future trajectory of the blood agar plate medium market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Dehydrated Powder
      • Horse Blood Powder
      • Human Blood Powder
      • Sheep Blood Powder
    • Pre Poured Plates
    • Ready To Use
  • Application
    • Clinical Diagnostics
      • Antibiotic Susceptibility Testing
      • Bacterial Infection Diagnosis
    • Food Safety Testing
    • Pharmaceutical Manufacturing
    • Research Laboratories
  • End User
    • Academic And Research Institutes
    • Diagnostic Laboratories
    • Hospitals And Clinics
    • Pharmaceutical Companies
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Online Sales
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Merck KGaA
  • bioMérieux SA
  • HiMedia Laboratories Pvt. Ltd.
  • Hardy Diagnostics, Inc.
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • Dutscher SAS
  • Eiken Chemical Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing preference for chromogenic differential blood agar media to accelerate bacterial pathogen identification and antibiotic susceptibility
5.2. Rising demand for ready-to-use blood agar plates with proprietary antibiotic supplementation for streamlined microbiological workflows
5.3. Integration of automated inoculation and digital colony counting technologies in blood agar testing workflows to enhance lab efficiency
5.4. Surge in research use of blood agar mediums enriched with 5% sheep blood for advanced immunoassays and bacterial virulence studies
5.5. Development of portable blood agar testing kits for point-of-care infectious disease diagnostics in resource-limited healthcare settings
5.6. Shift towards GMP-certified and ISO-accredited blood agar production facilities to meet stringent regulatory and quality assurance standards
5.7. Expansion of blood agar plates market driven by increasing antimicrobial resistance surveillance programs globally
5.8. Customized blood agar formulations incorporating selective inhibitors for targeted cultivation of fastidious pathogens in clinical labs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Agar Plate Medium Market, by Type
8.1. Introduction
8.2. Dehydrated Powder
8.2.1. Horse Blood Powder
8.2.2. Human Blood Powder
8.2.3. Sheep Blood Powder
8.3. Pre Poured Plates
8.4. Ready To Use
9. Blood Agar Plate Medium Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.2.1. Antibiotic Susceptibility Testing
9.2.2. Bacterial Infection Diagnosis
9.3. Food Safety Testing
9.4. Pharmaceutical Manufacturing
9.5. Research Laboratories
10. Blood Agar Plate Medium Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Diagnostic Laboratories
10.4. Hospitals And Clinics
10.5. Pharmaceutical Companies
11. Blood Agar Plate Medium Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Sales
12. Americas Blood Agar Plate Medium Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Blood Agar Plate Medium Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Blood Agar Plate Medium Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Becton, Dickinson and Company
15.3.3. Merck KGaA
15.3.4. bioMérieux SA
15.3.5. HiMedia Laboratories Pvt. Ltd.
15.3.6. Hardy Diagnostics, Inc.
15.3.7. Neogen Corporation
15.3.8. Bio-Rad Laboratories, Inc.
15.3.9. Dutscher SAS
15.3.10. Eiken Chemical Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD AGAR PLATE MEDIUM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BLOOD AGAR PLATE MEDIUM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BLOOD AGAR PLATE MEDIUM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BLOOD AGAR PLATE MEDIUM MARKET: RESEARCHAI
FIGURE 24. BLOOD AGAR PLATE MEDIUM MARKET: RESEARCHSTATISTICS
FIGURE 25. BLOOD AGAR PLATE MEDIUM MARKET: RESEARCHCONTACTS
FIGURE 26. BLOOD AGAR PLATE MEDIUM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BLOOD AGAR PLATE MEDIUM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY HORSE BLOOD POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY HORSE BLOOD POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY HUMAN BLOOD POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY HUMAN BLOOD POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY SHEEP BLOOD POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY SHEEP BLOOD POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY PRE POURED PLATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY PRE POURED PLATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY READY TO USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY READY TO USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY ANTIBIOTIC SUSCEPTIBILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY ANTIBIOTIC SUSCEPTIBILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY BACTERIAL INFECTION DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY BACTERIAL INFECTION DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 88. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 89. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 90. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 91. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 94. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 95. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 100. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 103. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 106. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 107. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. MEXICO BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 162. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 163. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 165. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 168. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 169. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. GERMANY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 174. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 175. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 176. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 177. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 180. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 181. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. FRANCE BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 198. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 199. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 200. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 201. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 204. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 205. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. ITALY BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 210. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 211. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 212. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 213. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 216. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 217. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. SPAIN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 258. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 259. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 260. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 261. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 264. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 265. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. DENMARK BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 282. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 283. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 284. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 285. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 288. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 289. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. QATAR BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 296. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 297. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 300. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 301. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. FINLAND BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY DEHYDRATED POWDER, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA BLOOD AGAR PLATE MEDIUM MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Blood Agar Plate Medium market report include:
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Merck KGaA
  • bioMérieux SA
  • HiMedia Laboratories Pvt. Ltd.
  • Hardy Diagnostics, Inc.
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • Dutscher SAS
  • Eiken Chemical Co., Ltd.